Attention Deficit
17
3
3
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.9%
1 terminated out of 17 trials
87.5%
+1.0% vs benchmark
0%
0 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (17)
Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
Cognitive and Postural Activities of Prematurely Born Children
Brain Activity Associated With Inhibition of Action in Attention-deficit
Effect of Fixed vs. Tailored Intensity tDCS for Attention Deficit After TBI
Computerized Training of Attention and Working Memory in Post COVID-19 Patients With Cognitive Complaints
A Multimodal Intervention Program for Children With Attention Deficits (Child ViReal Support Program)
Monitoring and Evaluation of a Cognitive Behavioral Therapy Program Focused on Attention and Emotion Regulation for Children With Fetal Alcohol Spectrum Disorder
Treatment With Cannabis Oil Containing CBD, THC, CBDV or CBG vs. Placebo of Persons With ADHD
Markers of Executive Attention Development in Preschoolers - Behavioral Measures in Various Populations
Identification of Biomarkers to Predict Driver Take-over Control Quality
Brain Markers of Improvements in Cognitive Functioning
Investigating Usability of c-SIGHT in the Homes of Brain Injury Survivors
Sublingual Glycine vs. Placebo on Attentional Difficulties and Hyperactivity in Prepuberal Children
Sleep and Exposure to Screens of Digital Media Devices in Israel
Can Stroke Patients and Their Caregiver Benefit From Additive Mindfulness Training
Based-virtual Reality Diagnosis for Neuropsychiatric Diseases and Sleep/Wake Disorders